Susquehanna International Group’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $309K | Buy |
115,232
+11,452
| +11% | +$30.7K | ﹤0.01% | 5000 |
|
|
2025
Q1 | $146K | Buy |
103,780
+52,582
| +103% | +$74.1K | ﹤0.01% | 5693 |
|
|
2024
Q4 | $102K | Buy |
+51,198
| New | +$102K | ﹤0.01% | 5688 |
|
|
2024
Q3 | – | Sell |
-54,126
| Closed | -$171K | – | 5584 |
|
|
2024
Q2 | $171K | Buy |
+54,126
| New | +$171K | ﹤0.01% | 4844 |
|
|
2024
Q1 | – | Sell |
-20,689
| Closed | -$34.3K | – | 5490 |
|
|
2023
Q4 | $34.3K | Buy |
+20,689
| New | +$34.3K | ﹤0.01% | 5598 |
|
|
2023
Q3 | – | Sell |
-18,788
| Closed | -$40.4K | – | 5505 |
|
|
2023
Q2 | $40.4K | Sell |
18,788
-7,240
| -28% | -$15.6K | ﹤0.01% | 5248 |
|
|
2023
Q1 | $50.8K | Buy |
26,028
+12,065
| +86% | +$23.5K | ﹤0.01% | 5441 |
|
|
2022
Q4 | $53.6K | Sell |
13,963
-3,959
| -22% | -$15.2K | ﹤0.01% | 5145 |
|
|
2022
Q3 | $86K | Buy |
+17,922
| New | +$86K | ﹤0.01% | 5329 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5733 |
|
|
2022
Q1 | – | Sell |
-25,866
| Closed | -$522K | – | 5677 |
|
|
2021
Q4 | $522K | Buy |
+25,866
| New | +$522K | ﹤0.01% | 3734 |
|
|
2021
Q3 | – | Sell |
-32,124
| Closed | -$782K | – | 5281 |
|
|
2021
Q2 | $782K | Sell |
32,124
-67,164
| -68% | -$1.63M | ﹤0.01% | 3323 |
|
|
2021
Q1 | $2.42M | Buy |
99,288
+90,694
| +1,055% | +$2.21M | ﹤0.01% | 1888 |
|
|
2020
Q4 | $275K | Buy |
+8,594
| New | +$275K | ﹤0.01% | 3974 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4373 |
|